10x Genomics TXG
NASDAQ TXG
$63.20 +1.55 (+2.52%)
As of: Sep 3, 2026 · 3:59 PM EDT

10x Genomics (TXG) Cash from Investing Activities Growth (3y) (2021 - 2026)

Analysis

10x Genomics (TXG) Cash from Investing Activities Growth (3y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Veeva Systems 46.14 Bn 38.90 Bn 695.95 Mn 53.18%
2 BrightSpring Health Services 12.64 Bn 12.07 Bn 492.75 Mn 14.62%
3 Tempus AI 11.63 Bn 10.82 Bn 274.25 Mn -
4 Healthequity 8.23 Bn 7.98 Bn 257.95 Mn -36.24%
5 10x Genomics 8.23 Bn 7.68 Bn 112.50 Mn -20.13%
6 Hinge Health 7.20 Bn 6.81 Bn 183.95 Mn -
7 MiniMed 6.10 Bn 5.81 Bn 480.00 Mn -
8 Waystar Holding 4.99 Bn 4.80 Bn 221.99 Mn -
9 Doximity 4.92 Bn 4.23 Bn 132.93 Mn -1.25%
10 Heartflow 4.30 Bn 3.92 Bn 53.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.13%
Mar 31, 2026 -26.22%
Dec 31, 2025 62.11%
Sep 30, 2025 35.39%
Jun 30, 2025 67.57%
Mar 31, 2025 80.56%
Dec 31, 2024 -23.16%
Sep 30, 2024 43.66%
Jun 30, 2024 41.28%
Mar 31, 2024 30.84%
Dec 31, 2023 37.30%
Sep 30, 2023 79.05%
Jun 30, 2023 12.84%
Mar 31, 2023 156.36%
Dec 31, 2022 -71.46%
Sep 30, 2022 -33.62%
Jun 30, 2022 -27.95%
Mar 31, 2022 -201.83%
Dec 31, 2021 -113.72%